Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | (FY)Sep 30, 2017 | (FY)Sep 30, 2016 | (FY)Sep 30, 2015 | (FY)Sep 30, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -38.48%94.82M | -96.99%154.12M | 14.34%5.12B | -22.30%4.48B | 270.21%5.77B | -65.88%1.56B | 293.42%4.57B | -204.65%-2.36B | 460.67%2.26B | 86.82%-625.56M |
Net profit before non-cash adjustment | -524.18%-486.98M | 105.50%114.81M | 46.35%-2.09B | -1,929.25%-3.89B | -85.62%212.65M | 115.57%1.48B | -406.80%-9.5B | 35.03%3.1B | 422.15%2.29B | -64.03%439.17M |
Total adjustment of non-cash items | 1,549.61%506.91M | -101.75%-34.97M | -4.49%2B | 4.09%2.1B | 149.88%2.01B | -84.27%805.42M | 675.57%5.12B | 13.70%-889.66M | -334.48%-1.03B | 275.38%439.68M |
-Depreciation and amortization | 49.68%711K | -99.88%475K | 3.31%394.68M | 14.48%382.04M | -1.23%333.71M | 27.35%337.88M | 16.34%265.32M | 5.39%228.07M | 46.45%216.4M | 89.67%147.77M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --519.14M | ---- | ---- | ---- | --13.1M | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 62.00%-283.48M | -357.27%-745.92M | -44.55%289.93M |
-Share of associates | 741.52%493.81M | 200.56%58.68M | -137.50%-58.35M | 188.36%155.59M | 61.61%-176.1M | -108.50%-458.68M | 4,275.44%5.39B | 228.88%123.28M | 3.74%-95.66M | -839.44%-99.37M |
-Disposal profit | --0 | --0 | 128.32%1.16B | --506.62M | --0 | --0 | --90.63M | --0 | -533.53%-312.42M | 73.99%-49.31M |
-Net exchange gains and losses | 103.52%3.83M | -993.26%-108.86M | -131.43%-9.96M | 3,470.00%31.68M | -104.94%-940K | 103.84%19.03M | -2,372.73%-495.44M | 93.50%-20.04M | -17,165.13%-308.01M | 94.80%-1.78M |
-Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.33%3.01M | -23.96%12.2M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -137.45%-3.03M | -58.70%8.09M | --19.58M |
-Other non-cash items | -41.89%8.56M | 1,309.44%14.73M | -100.12%-1.22M | -45.09%1.02B | 104.58%1.86B | 716.70%907.19M | 84.26%-147.11M | -559.04%-934.47M | 68.69%203.57M | 119.06%120.68M |
Changes in working capital | 0.81%74.88M | -98.57%74.28M | -16.98%5.21B | 77.15%6.28B | 588.06%3.54B | -108.12%-726.01M | 295.85%8.95B | -559.50%-4.57B | 166.08%994.1M | 73.68%-1.5B |
-Change in receivables | 221.36%21.27M | -100.27%-17.53M | 123.96%6.6B | -25.88%2.95B | 533.41%3.97B | -159.84%-917.14M | 5,803.17%1.53B | -300.90%-26.87M | 555.74%13.38M | -103.76%-2.94M |
-Change in inventory | 66.58%2.04M | -98.63%1.22M | 328.57%89.12M | -75.41%20.8M | 3,355.20%84.57M | 97.85%-2.6M | -1,557.67%-120.63M | 88.60%-7.28M | -235.03%-63.83M | 464.04%47.27M |
-Change in payables | 102.66%155K | 92.81%-5.83M | 82.61%-81.08M | -80.94%-466.23M | -698.76%-257.67M | -83.01%43.03M | 167.92%253.24M | -2,490.83%-372.87M | 146.97%15.6M | 147.06%6.32M |
-Provision for loans, leases and other losses | -46.67%51.42M | 106.91%96.41M | -136.95%-1.4B | 1,560.72%3.78B | -271.55%-258.52M | -97.93%150.7M | --7.28B | ---- | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -504.38%-4.16B | 166.17%1.03B | 73.04%-1.56B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0 | 87.63%-67.7M | -206.92%-547.11M | 69.56%-178.26M | -85.09%-585.63M | 67.69%-316.41M | -1,238.47%-979.18M | -234.22%-73.16M | 34.50%-21.89M | -985.29%-33.42M |
Interest received (cash flow from operating activities) | -7.11%19.75M | -87.85%21.27M | 2.14%175.08M | -49.48%171.42M | 77.72%339.28M | 35.86%190.91M | 181.41%140.52M | -82.21%49.94M | 1,286.83%280.74M | 1.18%20.24M |
Tax refund paid | 54.34%-28.92M | 57.31%-63.34M | 72.36%-148.37M | 8.36%-536.81M | -24.28%-585.79M | 37.63%-471.33M | -53.15%-755.66M | -127.44%-493.42M | 27.68%-216.95M | 2.34%-299.98M |
Other operating cash inflow (outflow) | 0 | 0.00%-1K | 0.00%-1K | -1K | 0 | -1K | 0 | 0 | 0.00%-1K | 0.00%-1K |
Operating cash flow | 93.15%85.65M | -99.04%44.34M | 16.92%4.6B | -20.22%3.94B | 413.48%4.94B | -67.66%961.37M | 203.29%2.97B | -225.22%-2.88B | 344.82%2.3B | 81.36%-938.72M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | --0 | 93.86%-6.98M | 12.48%-113.69M | -120.51%-129.9M | 47.05%-58.91M | 39.69%-111.26M | -41.82%-184.47M | 4.88%-130.07M | -6.21%-136.75M | -268.80%-128.76M |
Net intangibles purchase and sale | ---848K | --0 | ---- | 96.88%-1.34M | 79.52%-43.07M | 32.59%-210.3M | -397.58%-311.98M | 18.74%-62.7M | -45.08%-77.16M | -2,869.40%-53.18M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---7.8B | ---- | ---- | ---- |
Net investment product transactions | ---- | ---- | --230.43M | ---- | ---- | 107.67%165.62M | ---2.16B | ---- | ---- | -1,702.77%-1.82B |
Advance cash and loans provided to other parties | -1,605.69%-510.69M | 56.60%-29.94M | -107.43%-68.99M | 38.68%-33.26M | 64.09%-54.24M | -202.77%-151.05M | 74.60%-49.89M | 97.16%-196.41M | -69,897.83%-6.92B | 98.08%-9.89M |
Repayment of advance payments to other parties and cash income from loans | 1,036.13%181.78M | 138.81%16M | -87.77%6.7M | -61.84%54.78M | 49.87%143.56M | -25.06%95.79M | -1.32%127.82M | -81.81%129.52M | 891.42%712.19M | -27.17%71.84M |
Net changes in other investments | -99.58%52K | 8,030.97%12.29M | 99.89%-155K | -191.78%-138.82M | -277.25%-47.58M | 102.67%26.84M | -1,718.41%-1.01B | 120.27%62.2M | -261.46%-306.85M | 144.71%190.05M |
Investing cash flow | -3,723.50%-329.7M | -115.88%-8.62M | 121.85%54.3M | -312.60%-248.55M | 67.32%-60.24M | 98.38%-184.36M | -5,663.95%-11.38B | 97.07%-197.46M | -285.21%-6.73B | -83.51%-1.75B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -430.97%-21M | 99.93%-3.96M | -176.87%-5.84B | 59.06%-2.11B | -454.01%-5.15B | -131.74%-929.85M | -80.34%2.93B | 676.49%14.9B | -37.72%1.92B | -32.50%3.08B |
Net common stock issuance | --709.1M | --0 | ---- | ---- | ---- | -99.10%1.53M | -95.37%169.77M | -24.75%3.66B | 747.63%4.87B | -70.63%574.28M |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | -85.04%-903.63M | -213.75%-488.35M | -39.69%-155.65M | 66.31%-111.43M |
Net other fund-raising expenses | ---- | ---- | ---- | 50.00%-1K | -100.03%-2K | -96.16%6.96M | 1,083.62%181.08M | -920,550.00%-18.41M | --2K | ---- |
Financing cash flow | 17,498.23%688.1M | 99.93%-3.96M | -176.87%-5.84B | 59.06%-2.11B | -459.11%-5.15B | -138.77%-921.36M | -86.84%2.38B | 172.34%18.06B | 87.09%6.63B | -42.73%3.54B |
Net cash flow | ||||||||||
Beginning cash position | 31.90%234.06M | -98.63%177.45M | 15.83%12.98B | -11.52%11.21B | -2.79%12.67B | -21.95%13.03B | 346.89%16.7B | 150.38%3.74B | 173.44%1.49B | 59.05%545.82M |
Current changes in cash | 1,297.95%444.05M | 102.69%31.76M | -174.73%-1.18B | 674.17%1.58B | -90.69%-275.27M | 97.61%-144.35M | -140.25%-6.03B | 581.67%14.99B | 156.09%2.2B | 326.71%858.42M |
Effect of exchange rate changes | 61.43%-990K | -101.77%-2.57M | -25.48%144.69M | 116.39%194.16M | -438.87%-1.18B | -109.29%-219.87M | 217.01%2.37B | -22,738.48%-2.02B | -89.88%8.93M | 5,858.74%88.25M |
Cash adjustments other than cash changes | -100.00%-1K | 100.23%27.41M | ---11.77B | ---- | ---- | -200.00%-1K | 150.00%1K | -100.01%-2K | 3,717,000.00%37.17M | ---1K |
End cash Position | 189.29%677.11M | 31.90%234.06M | -98.63%177.45M | 15.83%12.98B | -11.52%11.21B | -2.79%12.67B | -21.95%13.03B | 346.89%16.7B | 150.38%3.74B | 173.44%1.49B |
Free cash flow | 126.94%84.8M | -99.17%37.37M | 17.96%4.49B | -21.25%3.81B | 655.61%4.83B | -74.16%639.81M | 180.64%2.48B | -247.32%-3.07B | 285.98%2.08B | 77.91%-1.12B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |